143 related articles for article (PubMed ID: 9389417)
1. Immunophenotyping of insulitis in control and essential fatty acid deficient mice treated with multiple low-dose streptozotocin.
Fraser RB; Rowden G; Colp P; Wright JR
Diabetologia; 1997 Nov; 40(11):1263-8. PubMed ID: 9389417
[TBL] [Abstract][Full Text] [Related]
2. Essential fatty acid deficiency prevents multiple low-dose streptozotocin-induced diabetes in CD-1 mice.
Wright JR; Lefkowith JB; Schreiner G; Lacy PE
Proc Natl Acad Sci U S A; 1988 Aug; 85(16):6137-41. PubMed ID: 3045812
[TBL] [Abstract][Full Text] [Related]
3. Low dose streptozotocin causes diabetes in severe combined immunodeficient (SCID) mice without immune cell infiltration of the pancreatic islets.
Reddy S; Wu D; Elliott RB
Autoimmunity; 1995; 20(2):83-92. PubMed ID: 7578872
[TBL] [Abstract][Full Text] [Related]
4. The anti-diabetogenic effect of essential fatty acid deficiency in multiple low-dose streptozotocin-treated mice persists if essential fatty acid repletion occurs outside of a brief window of susceptibility.
Wright JR; Haliburton B; Russell H; Henry M; Fraser R; Cook HW
Diabetologia; 1991 Oct; 34(10):709-14. PubMed ID: 1835705
[TBL] [Abstract][Full Text] [Related]
5. Temporal relationship between immune cell influx and the expression of inducible nitric oxide synthase, interleukin-4 and interferon-gamma in pancreatic islets of NOD mice following adoptive transfer of diabetic spleen cells.
Reddy S; Karanam M; Krissansen G; Nitschke K; Neve J; Poole CA; Ross JM
Histochem J; 2000 Apr; 32(4):195-206. PubMed ID: 10872884
[TBL] [Abstract][Full Text] [Related]
6. Essential fatty acid deficiency prevents multiple low-dose streptozotocin-induced diabetes in naive and cyclosporin-treated low-responder murine strains.
Wright JR; Fraser RB; Kapoor S; Cook HW
Acta Diabetol; 1995 Jun; 32(2):125-30. PubMed ID: 7579534
[TBL] [Abstract][Full Text] [Related]
7. Intrathymic transplantation of islet antigen affects CD8+ diabetogenic T-cells resulting in tolerance to autoimmune IDDM.
Baumann EE; Buckingham F; Herold KC
Diabetes; 1995 Aug; 44(8):871-7. PubMed ID: 7621990
[TBL] [Abstract][Full Text] [Related]
8. Low dose streptozotocin-induced diabetes in rat insulin promoter-mCD80-transgenic mice is T cell autoantigen-specific and CD28 dependent.
Pechhold K; Patterson NB; Blum C; Fleischacker CL; Boehm BO; Harlan DM
J Immunol; 2001 Feb; 166(4):2531-9. PubMed ID: 11160314
[TBL] [Abstract][Full Text] [Related]
9. An immunohistochemical study of macrophage influx and the co-localization of inducible nitric oxide synthase in the pancreas of non-obese diabetic (NOD) mice during disease acceleration with cyclophosphamide.
Reddy S; Yip S; Karanam M; Poole CA; Ross JM
Histochem J; 1999 May; 31(5):303-14. PubMed ID: 10461865
[TBL] [Abstract][Full Text] [Related]
10. Transgenic expression of interleukin 10 in the pancreas renders resistant mice susceptible to low dose streptozotocin-induced diabetes.
Mueller R; Lee MS; Sawyer SP; Sarvetnick N
J Autoimmun; 1996 Apr; 9(2):151-8. PubMed ID: 8738958
[TBL] [Abstract][Full Text] [Related]
11. Low-dose streptozocin-induced autoimmune diabetes in islet transplantation model.
Weide LG; Lacy PE
Diabetes; 1991 Sep; 40(9):1157-62. PubMed ID: 1834505
[TBL] [Abstract][Full Text] [Related]
12. Newly weaned nonobese diabetic mice show heightened early diabetes sensitivity to multiple low doses of streptozotocin than nondiabetes-prone CD-1 mice: initial beta-cell damage a key trigger for type 1 diabetes?
Reddy S; Elliott RB; Chang M; Hsu T; Rodrigues JA; Qiao L; Robinson E
Pancreas; 2008 Jul; 37(1):e8-e19. PubMed ID: 18580436
[TBL] [Abstract][Full Text] [Related]
13. Very-low-dose streptozotocin induces diabetes in insulin promoter-mB7-1 transgenic mice.
Harlan DM; Barnett MA; Abe R; Pechhold K; Patterson NB; Gray GS; June CH
Diabetes; 1995 Jul; 44(7):816-23. PubMed ID: 7540575
[TBL] [Abstract][Full Text] [Related]
14. Role of uncoupling protein UCP2 in cell-mediated immunity: how macrophage-mediated insulitis is accelerated in a model of autoimmune diabetes.
Emre Y; Hurtaud C; Karaca M; Nubel T; Zavala F; Ricquier D
Proc Natl Acad Sci U S A; 2007 Nov; 104(48):19085-90. PubMed ID: 18006654
[TBL] [Abstract][Full Text] [Related]
15. Diabetes induced with low doses of streptozotocin is mediated by V beta 8.2+ T-cells.
Herold KC; Bloch TN; Vezys V; Sun Q
Diabetes; 1995 Mar; 44(3):354-9. PubMed ID: 7883124
[TBL] [Abstract][Full Text] [Related]
16. Macrophage infiltration precedes and is a prerequisite for lymphocytic insulitis in pancreatic islets of pre-diabetic BB rats.
Hanenberg H; Kolb-Bachofen V; Kantwerk-Funke G; Kolb H
Diabetologia; 1989 Feb; 32(2):126-34. PubMed ID: 2656351
[TBL] [Abstract][Full Text] [Related]
17. Initial role of macrophage in the development of anti-beta-cell cellular autoimmunity in multiple low-dose streptozotocin-induced diabetes in mice.
Ihm SH; Lee KU; Rhee BD; Min HK
Diabetes Res Clin Pract; 1990 Oct; 10(2):123-6. PubMed ID: 2175696
[TBL] [Abstract][Full Text] [Related]
18. Streptozotocin-induced pancreatic insulitis in mice. Morphologic and physiologic studies.
Like AA; Appel MC; Williams RM; Rossini AA
Lab Invest; 1978 Apr; 38(4):470-86. PubMed ID: 205725
[TBL] [Abstract][Full Text] [Related]
19. The effect of immunosuppression on streptozotocin-induced diabetes in C57BL/KsJ mice.
Leiter EH; Beamer WG; Shultz LD
Diabetes; 1983 Feb; 32(2):148-55. PubMed ID: 6219026
[TBL] [Abstract][Full Text] [Related]
20. In vivo microscopy of murine islets of Langerhans: increased adhesion of transferred lymphocytes to islets depends on macrophage-derived cytokines in a model of organ-specific insulitis.
Ludwig R; Kretschmer M; Caspar G; Bojunga J; Oldenburg A; Schumm-Draeger P; Stegmüller M; von Minckwitz G; Usadel KH; Kusterer K
Immunology; 1999 Sep; 98(1):111-5. PubMed ID: 10469241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
